Alza Corp. is suing Impax Laboratories Inc. for patent infringement for the Hayward company’s generic version of blockbuster attention deficit hyperactivity disorder Concerta.
Concerta extended-release tablets, ranging from 18 milligrams to 54 milligrams, registered sales of $1.4 billion in the 12 months ended in February.
No comments:
Post a Comment